⌘K

Login Start Free

Home/Filings/4/0001056520-11-000549

4//SEC Filing

LIEBER RANDY 4

Accession 0001056520-11-000549

CIK 0001325279other

View on SEC.gov Company Profile

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 4:26 PM ET

Size

7.0 KB

Accession

0001056520-11-000549

Insider Transaction Report

Form 4

Period: 2011-11-08

CELLCYTE GENETICS CORPccyg

DirectorPrincipal Accounting Officer

Transactions

Award
Option
2011-11-08$0.02/sh+6,000,000$96,000→ 13,200,000 total
Exercise: $0.02From: 2011-11-08Exp: 2016-11-08→ Common (6,000,000 underlying)
Award
Common Stock
2011-11-08$0.02/sh+4,000,000$64,000→ 5,664,150 total

Footnotes (1)

[F1]Options shall vest and underlying shares shall become exercisable linearly per month, beginning on the first day of each month. On the first day of each month, so long as Mr. Lieber is a director of the Company, 500,000 options shall become exercisable.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

CELLCYTE GENETICS CORP

CIK 0001325279

Entity typeother

Related Parties

1

filerCIK 0001465074

Filing Metadata

Form type: 4
Filed: Nov 28, 7:00 PM ET
Accepted: Nov 29, 4:26 PM ET
Size: 7.0 KB

View on SEC.gov